IVBT (Innovation1 Biotech) Days Payable: 0.00 (As of Feb. 2024)


IVBT Innovation1 Biotech Inc IVBT
12 GF Score
Price $0.00
View Full Analysis

What is Innovation1 Biotech Days Payable?

Innovation1 Biotech IVBT 12 Days Payable is 0.00 as of Feb. 2024. GuruFocus rates IVBT with a GF Score™ of 12/100.

Innovation1 Biotech's average Accounts Payable for the three months ended in Feb. 2024 was $0.36 Mil. Innovation1 Biotech's Cost of Goods Sold for the three months ended in Feb. 2024 was $0.00 Mil.

The historical rank and industry rank for Innovation1 Biotech's Days Payable or its related term are showing as below:

IVBT's Days Payable is not ranked *
in the Diversified Financial Services industry.
Industry Median: 71.76
* Ranked among companies with meaningful Days Payable only.

Innovation1 Biotech's Days Payable stayed the same from Feb. 2023 (0.00) to Feb. 2024 (0.00). stayed the same

Innovation1 Biotech Days Payable Historical Data

* Premium members only.

The historical data trend for Innovation1 Biotech's Days Payable can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Innovation1 Biotech Days Payable Chart

Innovation1 Biotech Annual Data
Trend Aug15 Aug16 Aug17 Aug18 Aug19 Aug20 Aug21 Aug22 Aug23
Days Payable
Get a 7-Day Free Trial Premium Member Only 289.13 29,747.50 88,512.50 0.00 0.00

Innovation1 Biotech Quarterly Data
May19 Aug19 Nov19 Feb20 May20 Aug20 Nov20 Feb21 May21 Aug21 Nov21 Feb22 May22 Aug22 Nov22 Feb23 May23 Aug23 Nov23 Feb24
Days Payable Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.00 0.00 0.00 0.00 0.00

IVBT vs NVIV, PXMD, SCNI: Days Payable Comparison

For the Shell Companies subindustry, Innovation1 Biotech's Days Payable, along with its competitors' market caps and Days Payable data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Innovation1 Biotech Days Payable vs Diversified Financial Services Industry

For the Diversified Financial Services industry and Financial Services sector, Innovation1 Biotech's Days Payable distribution charts can be found below:

* The bar in red indicates where Innovation1 Biotech's Days Payable falls into.


IVBT
12GF Score
Innovation1 Biotech Inc IVBT
Days Payable is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Innovation1 Biotech Days Payable Calculation

Days Payable indicates the number of days that the account payable relative to cost of goods sold the company has. An increase of Days Payable may suggest that the company delays paying its suppliers.

Innovation1 Biotech's Days Payable for the fiscal year that ended in Aug. 2023 is calculated as

Days Payable (A: Aug. 2023 )
=Average Accounts Payable /Cost of Goods Sold*Days in Period
=( (Accounts Payable (A: Aug. 2022 ) + Accounts Payable (A: Aug. 2023 )) / count ) / Cost of Goods Sold (A: Aug. 2023 )*Days in Period
=( (0.106 + 0.349) / 2 ) / 0*365
=0.2275 / 0*365
=N/A

Innovation1 Biotech's Days Payable for the quarter that ended in Feb. 2024 is calculated as:

Days Payable (Q: Feb. 2024 )
=Average Accounts Payable / Cost of Goods Sold*Days in Period
=( (Accounts Payable (Q: Nov. 2023 ) + Accounts Payable (Q: Feb. 2024 )) / count ) / Cost of Goods Sold (Q: Feb. 2024 )*Days in Period
=( (0.357 + 0.355) / 2 ) / 0*365 / 4
=0.356 / 0*365 / 4
=N/A

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about Days Payable →
What does a Days Payable of 0.00 mean?
Innovation1 Biotech (IVBT) has a Days Payable of 0.00 as of Feb. 2024. Days payable represents the average amount of days a company waits to pay its invoices from suppliers. View historical data on Innovation1 Biotech and its competitors.
Is Innovation1 Biotech's Days Payable too high?
Innovation1 Biotech's current Days Payable is 0.00. Overall, Innovation1 Biotech has a GF Score™ of 12/100, reflecting its overall financial health beyond just this single metric.
How does Innovation1 Biotech's Days Payable compare to NVIV and PXMD?
Innovation1 Biotech's Days Payable of 0.00 can be compared against companies in the Diversified Financial Services industry. The industry median Days Payable is 71.76. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Days Payable for a Diversified Financial Services company?
The median Days Payable among Diversified Financial Services companies is 71.76, based on 82 companies in the industry. Companies in the top quartile (top 25%) have a Days Payable significantly above this median, while those in the bottom quartile fall well below. However, Days Payable should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Days Payable mean?
A high Days Payable can signal that a stock is expensive relative to its fundamentals. Days payable represents the average amount of days a company waits to pay its invoices from suppliers. View historical data on Innovation1 Biotech and its competitors. For the Diversified Financial Services industry, the median Days Payable is 71.76 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Innovation1 Biotech's current Days Payable is 0.00. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Innovation1 Biotech stock overvalued right now?
Innovation1 Biotech (IVBT) has a current Days Payable of 0.00. The current Days Payable is 0.00. Innovation1 Biotech's overall GF Score™ is 12/100. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Days Payable calculated?
Days Payable is calculated from a company's financial statements. For Innovation1 Biotech (IVBT), the current Days Payable is 0.00 as of Feb. 2024. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Innovation1 Biotech Business Description

Address 7 Grand View Avenue, Somerville, MA, USA, 02143
Innovation1 Biotech Inc is a shell company.
12GF Score

Get the complete analysis for IVBT

Days Payable is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

$0.00
Price